Efficacy of ipragliflozin on glucose metabolism

Trial Profile

Efficacy of ipragliflozin on glucose metabolism

Phase of Trial: Phase II

Latest Information Update: 01 Jan 2015

At a glance

  • Drugs Ipragliflozin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jan 2015 Primary endpoint "Beta cell function assessed by the oral glucose tolerance test" has been met, as per the results published in the Endocrine Journal.
    • 25 Oct 2014 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan
    • 05 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top